Transient EZH2 Suppression by Tazemetostat during <i>In Vitro</i> Expansion Maintains T-Cell Stemness and Improves Adoptive T-Cell TherapyYingqin Hou, Peng Wu, Brandon Dinner et al.|Cancer Immunology Research|2024Cited by 17
Transient EZH2 suppression by Tazemetostat during <i>in vitro</i> expansion maintains T cell stemness and improves adoptive T cell therapyYingqin Hou, Peng Wu, Yujie Shi et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 5